Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Organic Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN105315256A details high-purity Trelagliptin succinate synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN101074209A reveals a mild CuI-catalyzed route for high-purity isoindolinone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel phenazine photoinitiators with red-shifted absorption for UV-LED curing. Improved efficiency and low migration for coatings and inks.
Advanced preparation of cyclohexene carboxylates for neuraminidase inhibitors. Optimized route offers cost reduction and scalable manufacturing for API intermediates.
Novel 3-step route for Rivaroxaban intermediate reduces waste and cost. High purity API intermediate manufacturing via efficient isonitrification.
Novel benzyl-protected route for Pseudoceramide PMS synthesis. High yield, scalable process for reliable cosmetic ingredient manufacturing and supply.
Novel microwave synthesis method for dihydrazide phthalazine intermediates offers high purity and cost efficiency for pharmaceutical supply chains globally.
Novel patent CN105001114B offers high-purity Iopromide preparation. Reduces by-products and simplifies supply chain for contrast agent manufacturing.
Novel patent CN103992212A details high-purity cis-benvitimod synthesis. Offers supply chain stability and cost reduction for pharmaceutical intermediates manufacturing globally.
Patent CN106188136A reveals a water-based green synthesis for diphenyl thio(seleno)phosphonate, offering significant cost and supply chain advantages for agrochemical manufacturing.
Novel preparation method reduces cost and improves yield for Vortioxetine manufacturing ensuring supply chain stability and high purity standards for global pharmaceutical partners
Novel Lesinurad synthesis patent CN106866560A offers high yield and purity. Ideal for reliable pharmaceutical intermediates supplier seeking cost reduction.
Novel preparation method for Dolutegravir Impurity A and B via CN110655517A. Offers high-purity reference standards and scalable routes for HIV drug quality control.
Patent CN109096126B details a mild, high-yield synthesis for D9-Clenbuterol. Discover cost-effective production strategies for high-purity isotopic standards.
Patent CN111454270A discloses a novel six-membered ring nucleoside synthesis. Offers improved solubility and scalable routes for antiviral API manufacturing.
Patent CN102134224A reveals a solvent-free method for thiazoles and imidazoles. Achieve >98% purity with simplified workup, offering significant cost reduction in API manufacturing.
Discover the novel preparation method for Pemetrexed Diacid via CN103254196A. This route eliminates palladium catalysts and nitro groups, offering significant cost reduction and supply chain reliability for oncology API manufacturing.
Novel green synthesis of Delgocitinib intermediate avoiding protection groups, offering cost-effective supply chain solutions for JAK inhibitor production.
Patent CN113862708A reveals a metal-free electrochemical route for beta-cyano compounds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel one-step chlorination process reduces cost and waste for dye and polymer intermediates supply chain efficiency and purity standards globally.